Till startsida
To content Read more about how we use cookies on gu.se

Contact form


Note! If you want an answer on a question you must specify your email address

Kaj Blennow

Professor/ chief physician

Kaj Blennow
Professor/ chief physician

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Laborativ neurovetenskap , Göteborg

Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology (More Information)
Blå stråket 15, vån 3 SU/Sahlgrenska
413 45 Göteborg
031-342 10 00
Visiting Address: Blå stråket 15, vån 3 SU/Sahlgrenska , 413 45 Göteborg

About Kaj Blennow

Latest publications

Chemical Imaging of Evolving Amyloid Plaque Pathology and Associated Aβ Peptide Aggregation in a Transgenic Mouse Model of Alzheimer's Disease.
Wojciech Michno, Patrick M. Wehrli, Silvio Meier, Dag Sehlin, Stina Syvänen et al.
Journal of neurochemistry, Journal article 2020
Journal article

Acute symptomatic seizures and epilepsy after mechanical thrombectomy
Hanna Eriksson, Pia Löwhagen Hendén, Alexandros Rentzos, Fani Pujol-Calderón, Jan-Erik Karlsson et al.
Epilepsy and Behavior, Journal article 2020
Journal article

Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology.
Kaj Blennow, Chun Chen, Claudia Cicognola, Kristin R Wildsmith, Paul T Manser et al.
Brain : a journal of neurology, Journal article 2020
Journal article

Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders.
Sara Hall, Shorena Janelidze, Henrik Zetterberg, Britta Brix, Niklas Mattsson et al.
Movement disorders : official journal of the Movement Disorder Society, Journal article 2020
Journal article

Special Issue CCA for the proceedings of the 2nd symposium of the Society of CSF analysis and clinical neurochemistry.
Charlotte Teunissen, Lucilla Parnetti, Kaj Blennow, Markus Otto
Clinica chimica acta; international journal of clinical chemistry, Journal article 2020
Journal article

Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
E. H. Thijssen, R. La Joie, A. Wolf, A. Strom, P. Wang et al.
Nature Medicine, Journal article 2020
Journal article

Showing 1071 - 1080 of 1153


The transcobalamin 776C>G polymorphism may be a modifiable genetic risk factor for Alzheimer's disease
Henrik Zetterberg, Ebba Nexo, Lennart Minthon, Roberta Boson, Björn Regland et al.
Magazine article

The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease
Kina Höglund, K.M. Thelen, Steinar Syversen, Magnus Sjögren, K. Von Bergmann et al.
Dementia and Geriatric Cognitive Disorders, Journal article 2005
Journal article

Study of relative turnover of proteins from glioblastoma cell using differential arginine labeling
Annika Dahl, Kristina Hedberg-Fogel, Erik Portelius, Kaj Blennow, Ann Brinkmalm-Westman
HUPO (Human Proteome Organization), 2005, Munich, Germany, 29 Aug-1 Sept, Poster 2005

Methylenetetrahydrofolate reductase genetic polymorphisms in patients with cataract.
Madeleine Zetterberg, Gunnar Tasa, Jonathan A Prince, Mona Palmér, Erkki Juronen et al.
American journal of ophthalmology, Journal article 2005
Journal article

Simultaneous measurement of beta-amyloid((1-42)), total tau, and phosphorylated tau (Thr(181)) in cerebrospinal fluid by the xMAP technology
Annika Olsson, Hugo Vanderstichele, Niels Andreasen, Geert De Meyer, Anders Wallin et al.
Clinical Chemistry, Journal article 2005
Journal article

Standardized multiparameter quantification of biomarkers for Alzheimer’s disease in cerebrospinal fluid
H Vanderstichele, L Demeyer, K De Roo, S Van Remoortere, V Mortier et al.
Proceedings of the 7th International Congress of Alzheimer’s and Parkinson’s disease, Sorrento, Italy 2005 , Conference paper 2005
Conference paper

Mild cognitive impairment (MCI) and incipient Alzheimer disease – a role for biomarkers in CSF
N Andreasen, Kaj Blennow
Research and Practice in Alzheimer's Disease , Conference paper 2005
Conference paper

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.
J Wiltfang, P Lewczuk, P Riederer, E Grünblatt, C Hock et al.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, Review article 2005
Review article

Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study.
K Buerger, M Ewers, N Andreasen, R Zinkowski, K Ishiguro et al.
Neurology, Journal article 2005
Journal article

Showing 1071 - 1080 of 1153

Page Manager: Webbredaktör|Last update: 9/1/2015

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?